{"id":"W4402565894","doi":"10.1016/j.annonc.2024.08.2067","title":"1982P Post hoc analysis of outcomes according to prior chemotherapy (CT) response and platinum agent in the international SAUL study of atezolizumab (atezo) for urinary tract carcinoma (UTC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"Janssen Research and Development","keywords":"Atezolizumab; Medicine; Oncology; Post-hoc analysis; Cisplatin; Internal medicine; Post hoc; Platinum; Chemotherapy; Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006712855,0.001825803,0.00401873,0.0006536785,0.000562822,0.001578708,0.001946059,0.001442369,0.01090629],"category_scores_gemma":[0.007735264,0.0006456034,0.0090377,0.0007541275,0.0007059231,0.001690002,0.001160893,0.003934677,0.0006104562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008628112,"about_ca_system_score_gemma":0.002563019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005773323,"about_ca_topic_score_gemma":0.008373217,"domain_scores_codex":[0.9922253,0.004564155,0.0003117829,0.001282325,0.000389948,0.00122648],"domain_scores_gemma":[0.9937515,0.004329146,0.000384144,0.0007912535,0.0002556624,0.0004883286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7421743,0.003206675,0.1324883,0.001070106,0.05601023,0.001530062,0.0004993046,0.004925453,0.006646933,0.001344439,0.01873082,0.03137341],"study_design_scores_gemma":[0.0801766,0.115878,0.6977133,0.0003050664,0.04210399,0.0007774176,0.001309942,0.03557279,0.0052402,0.003432305,0.01721773,0.0002727485],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846993,0.001715096,0.003196596,0.0006432877,0.000936843,0.0003659119,0.005068202,0.0001023265,0.003272518],"genre_scores_gemma":[0.97891,0.0003577021,0.002139514,0.0007241074,0.0003504461,0.001210521,0.003948374,0.0001358226,0.01222348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01090629,"threshold_uncertainty_score":0.03648514,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08971721828821749,"score_gpt":0.4312705517660884,"score_spread":0.3415533334778709,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}